These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies. Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517 [TBL] [Abstract][Full Text] [Related]
45. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276 [TBL] [Abstract][Full Text] [Related]
46. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201 [TBL] [Abstract][Full Text] [Related]
47. Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia. Imamura H; Koreeda Y; Okadome T; Tara M; Niina K; Shizume K; Ohsumi K; Sato K Jpn J Clin Oncol; 1992 Oct; 22(5):325-30. PubMed ID: 1469794 [TBL] [Abstract][Full Text] [Related]
48. Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis. Tamura S; Takemoto Y; Wada H; Itoh T; Mori A; Saheki K; Okada M; Takatsuka H; Fujimori Y; Okamoto T; Kakishita E Br J Haematol; 1998 Jun; 101(4):743-8. PubMed ID: 9674749 [TBL] [Abstract][Full Text] [Related]
49. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study. Larson RA; Day RS; Azarnia N; Bennett JM; Browman G; Goldberg J; Gottlieb A; Grunwald H; Miller K; Raza A Br J Haematol; 1992 Oct; 82(2):337-46. PubMed ID: 1419816 [TBL] [Abstract][Full Text] [Related]
50. High expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I. Okada M; Furukawa K; Yamashiro S; Yamada Y; Haraguchi M; Horibe K; Kato K; Tsuji Y; Furukawa K Cancer Res; 1996 Jun; 56(12):2844-8. PubMed ID: 8665524 [TBL] [Abstract][Full Text] [Related]
53. Serum and leukocyte lactate dehydrogenase activity in leukaemias. Ghosh K; Malik K; Das KC Haematologia (Budap); 1988; 21(4):227-32. PubMed ID: 3209127 [TBL] [Abstract][Full Text] [Related]
54. [Analysis of correlation between serum thymidine kinase 1 and acute myeloid leukemia]. Wang TJ; Sun AN; Wu DP; Li WY; Liang JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1095-8. PubMed ID: 24156413 [TBL] [Abstract][Full Text] [Related]
55. Human T-lymphotropic virus type I in Japan. Yamaguchi K Lancet; 1994 Jan; 343(8891):213-6. PubMed ID: 7904671 [TBL] [Abstract][Full Text] [Related]
56. Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method. Kojima H; Hori M; Shibuya A; Nagasawa T; Miwa M; Abe T Cancer; 1993 Dec; 72(12):3614-7. PubMed ID: 8252476 [TBL] [Abstract][Full Text] [Related]
57. Acute myeloid leukaemia: results of the New Zealand AML-1 study. The Leukaemia Study Group of the New Zealand Society for Haematology. N Z Med J; 1991 Oct; 104(922):438-40. PubMed ID: 1923103 [TBL] [Abstract][Full Text] [Related]
58. Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome. Thomas X; Hirschauer C; Troncy J; Assouline D; Joly MO; Fiere D; Archimbaud E Leuk Lymphoma; 1997 Jan; 24(3-4):291-300. PubMed ID: 9156658 [TBL] [Abstract][Full Text] [Related]
59. Evidence for a bimodal relation between serum lysozyme and prognosis in 232 patients with acute myeloid leukaemia. Aström M; Bodin L; Hörnsten P; Wahlin A; Tidefelt U Eur J Haematol; 2003 Jan; 70(1):26-33. PubMed ID: 12631256 [TBL] [Abstract][Full Text] [Related]
60. Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer. Lehtinen M; Wigren T; Lehtinen T; Kallioniemi OP; Aine R; Aaran RK; Ojala A Tumour Biol; 1988; 9(6):287-92. PubMed ID: 2849799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]